Eden Research (LON:EDEN) Trading 26.5% Higher – Time to Buy?

Posted by Linda Flegge on May 14th, 2025

Eden Research plc (LON:EDEN – Get Free Report) traded up 26.5% on Wednesday . The company traded as high as GBX 3.48 ($0.05) and last traded at GBX 3.48 ($0.05). 778,726 shares changed hands during mid-day trading, an increase of 16% from the average session volume of 670,749 shares. The stock had previously closed at GBX 2.75 ($0.04).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a 50 day simple moving average of GBX 2.79 and a two-hundred day simple moving average of GBX 3.43. The company has a market cap of £20.27 million, a PE ratio of -13.31 and a beta of 0.92.

Eden Research (LON:EDEN – Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. Equities analysts predict that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Buying and Selling at Eden Research

In related news, insider Alexander John Abrey purchased 167,947 shares of the business’s stock in a transaction dated Tuesday, March 4th. The stock was acquired at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,705.36). Also, insider Sean M. Smith purchased 426,986 shares of the business’s stock in a transaction dated Tuesday, April 1st. The shares were bought at an average price of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). 14.02% of the stock is owned by company insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.